RSV Webinar series - Introduction
As the world is dealing with the insistent daily spread of the novel coronavirus, ReSViNET Foundation wants to ensure the continuation of RSV education. Therefore, the ReSViNET Foundation has started a bi-monthly RSV Webinar Series on the latest developments in the RSV field. Each webinar will be based on a Paper of the Month (see publications), which will be discussed by one of the authors and a moderator, who will both be experts in the field. Participants will be able to ask questions and share their ideas with the presenters.
|
By means of this webinar series we strive to continue RSV education in an uncertain and changing environment due to the global COVID-19 pandemic. |
On this online platform, we will keep you updated on the rapid progressions in the field of RSV research and preventive and therapeutic interventions. |
We offer opportunities to interact with original authors and experts in the RSV field. So, together we can have an active learning experience. |
|
|
Next webinar |
3. NEUTROPHILIC INFLAMMATION IN THE RESPIRATORY MUCOSA PREDISPOSES TO RSV INFECTION
JanUARY 27th, 2021 16:00 - 17:00 CET
|
Why does RSV exposure in one individual lead to disease, while another individual does not experience symptoms at all? This webinar will focus on the mucosal neutrophil activation as a new factor involved in RSV susceptibility and protection. These findings shed light on mechanisms of viral susceptibility and suggest new targets for RSV intervention. Through interactive discussion and interview with guest speaker, prof. dr. Peter Openshaw and co-host, prof. dr. Linde Meyaard, participants can ask questions directly to the speaker and they can take back lessons learned from these findings to their own research.
|
|
|
Webinar replays |
2. Lessons learned from the novavax phase 3 maternal vaccination trial
NovEMBER 20th, 2020
|
This webinar is focussed on the outcomes of the Novavax phase 3 maternal vaccination trial examining the differential effect of vaccine efficacy in HICs versus LMICs. Through interactive discussion and interview with guest speaker, prof. Shabir Madhi, and co-host, dr. Jessie Groothuis, participants were able to ask questions directly to the speaker and expand on the lessons learned from this trial in their own research.
Hosted by Prof. dr. Louis Bont and moderated and organized by: Amber Dassen, Sophie Mazur and Leyla Kragten-Tabatabaie. |
|
1. HOW TO DESIGN AND MAKE YOUR OWN VACCINE PROTEIN?
SepTEMBER 24th, 2020
|
This webinar is focussed on the novel development of the computationally designed protein-based vaccine using TopoBuilder, a protein design algorithm. Through interactive discussion and interview with guest speaker, dr. Fabian Sesterhenn, participants were able to ask questions directly to the speaker and learned skills which they can take back to their own research.
Hosted by Prof. dr. Louis Bont and moderated and organised by: Amber Dassen, Sophie Mazur and Leyla Kragten-Tabatabaie. |
